Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–2472.
   PubMed Web of Science ®Google Scholar
• N CCC, Kit-Fai L, Cheuk-Man C, et al. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2018;20(6):546–554.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
   PubMed Web of Science ®Google Scholar
• Xie DY, Ren ZG, Zhou J, et al. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4):452–463.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Huang H, Liang P, Yu XL, et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia. 2015;31(1):40–47.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liang P, Cheng ZG, et al. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia. 2014;30(2):134–141.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34(6):863–869.
   PubMed Web of Science ®Google Scholar
• Worakitsitisatorn A, Lu DS, Lee MW, et al. Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety. Eur Radiol. 2020;30(3):1813–1821.
   PubMed Web of Science ®Google Scholar
• Liu F, Yu X, Cheng Z, et al. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma. Eur J Radiol. 2017;91:93–98.
   PubMed Web of Science ®Google Scholar
• Liu C, He J, Li T, et al. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases. Abdom Radiol (NY). 2021;46(5):2161–2172.
   PubMed Web of Science ®Google Scholar
• Bhagavatula SK, Chick JF, Chauhan NR, et al. Artificial ascites and pneumoperitoneum to facilitate thermal ablation of liver tumors: a pictorial essay. Abdom Radiol (NY). 2017;42(2):620–630.
   PubMed Web of Science ®Google Scholar
• Liu SR, Liang P, Yu XL, et al. Percutaneous microwave ablation for liver tumours adjacent to the marginal angle. Int J Hyperthermia. 2014;30(5):306–311.
   PubMed Web of Science ®Google Scholar
• Zhi-Yu H, Ping L, Xiao-Ling Y, et al. A clinical study of thermal monitoring techniques of ultrasound-guided microwave ablation for hepatocellular carcinoma in high-risk locations. Sci Rep. 2017;7(1):41246.
   PubMed Web of Science ®Google Scholar
• Liu FY, Yu XL, Liang P, et al. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012;81(7):1455–1459.
   PubMed Web of Science ®Google Scholar
• Liu F, Cheng Z, Han Z, et al. A three-dimensional visualization preoperative treatment planning system for microwave ablation in liver cancer: a simulated experimental study. Abdom Radiol. 2017;42(6):1788–1793.
   PubMed Web of Science ®Google Scholar
• Ren H, An C, Liang P, et al. Ultrasound-guided percutaneous microwave ablation assisted by athree-dimensional visualization treatment platform combined with transcatheter arterial chemoembolization for a single large hepatocellular carcinoma 5 cm or larger: a preliminary clinical application]. Int J Hyperthermia. 2019;36(1):44–54.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Mori K, Hasegawa N, et al. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide. Jpn J Radiol. 2019;37(7):555–563.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Basten LM, Nour-Eldin NA, et al. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. Int J Hyperthermia. 2018;34(4):492–500.
   PubMed Web of Science ®Google Scholar
• Liu F, Liang P, Yu X, et al. A three-dimensional visualisation preoperative treatment planning system in microwave ablation for liver cancer: a preliminary clinical application. Int J Hyperthermia. 2013;29(7):671–677.
   PubMed Web of Science ®Google Scholar
• Yang B, Zou J, Xia J, et al. Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation. Eur J Radiol. 2011;79(2):196–200.
   PubMed Web of Science ®Google Scholar
• Komatsu S, Murakami M, Fukumoto T, et al. Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma. Br J Surg. 2011;98(4):558–564.
   PubMed Web of Science ®Google Scholar
• Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38(10):977–981.
   PubMed Web of Science ®Google Scholar
• Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232(1):10–24.
   PubMed Web of Science ®Google Scholar
• Kang TW, Lim HK, Lee MW, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology. 2016;280(1):300–312.
   PubMed Web of Science ®Google Scholar
• Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66(6):1172–1173.
   PubMed Web of Science ®Google Scholar
• Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43(5):1101–1108.
   PubMed Web of Science ®Google Scholar
• Francica G, Meloni MF, DE Sio I, et al. Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy. Eur J Radiol. 2016;85(4):739–743.
   PubMed Web of Science ®Google Scholar
• Liang P, Wang Y, Yu X, et al. Malignant liver tumors: treatment with percutaneous microwave ablation–complications among cohort of 1136 patients. Radiology. 2009;251(3):933–940.
   PubMed Web of Science ®Google Scholar